Zhao H G, Aronovich E L, Whitley C B
Gene Therapy Program, Institute of Human Genetics, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.
Am J Hum Genet. 1998 Jan;62(1):53-63. doi: 10.1086/301682.
Sanfilippo syndrome type B, or mucopolysaccharidosis type IIIB, results from defects in the gene for alpha-N-acetylglucosaminidase (NAGLU); only a few mutations have been described. To rapidly identify most NAGLU mutations, an automated sequencing procedure was developed for analysis of the entire coding region, including exon-intron borders. By this method, eight affected families were studied, and the mutations in all 16 alleles were identified, more than doubling the number of published mutations for this gene. Eight mutations were described for the first time: five missense mutations (Y140C, Y455C, P521L, S612G, and R674C), two nonsense mutations (W675X and Q706X), and one 24-nucleotide insertion. Currently, 36% of all point mutations (8 of 22 alleles) involve R674, a codon having a CpG dinucleotide in the critical initial position. Other mutations were found in more than one family, raising the possibility that some may be relatively common and, possibly, ancient mutations. Six new nonpathological mutations were also identified and likely represent polymorphic variants of the NAGLU gene, two of which might alter enzyme level. Establishing genotype-phenotype relationships will be vital in the evaluation of experimental treatments such as gene therapy.
B型Sanfilippo综合征,即IIIB型粘多糖贮积症,是由α-N-乙酰氨基葡萄糖苷酶(NAGLU)基因缺陷引起的;仅发现了少数几种突变。为了快速鉴定大多数NAGLU突变,开发了一种自动测序程序,用于分析包括外显子-内含子边界在内的整个编码区。通过这种方法,对8个患病家族进行了研究,确定了所有16个等位基因中的突变,使该基因已发表的突变数量增加了一倍多。首次描述了8种突变:5种错义突变(Y140C、Y455C、P521L、S612G和R674C)、2种无义突变(W675X和Q706X)和1种24个核苷酸的插入突变。目前,所有点突变的36%(22个等位基因中的8个)涉及R674,该密码子在关键起始位置有一个CpG二核苷酸。在不止一个家族中发现了其他突变,这增加了某些突变可能相对常见且可能是古老突变的可能性。还鉴定出6种新的非病理性突变,可能代表NAGLU基因的多态性变体,其中两种可能会改变酶水平。建立基因型-表型关系对于评估基因治疗等实验性治疗至关重要。